Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Return on Equity (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Return on Equity data on record, last reported at 0.53% in Q4 2025.

  • For Q4 2025, Return on Equity fell 5.0% year-over-year to 0.53%; the TTM value through Dec 2025 reached 0.53%, down 5.0%, while the annual FY2025 figure was 0.49%, 28.0% up from the prior year.
  • Return on Equity reached 0.53% in Q4 2025 per PRAX's latest filing, up from 0.78% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.41% in Q2 2024 and bottomed at 2.62% in Q1 2023.
  • Average Return on Equity over 4 years is 1.12%, with a median of 0.78% recorded in 2025.
  • Peak YoY movement for Return on Equity: soared 175bps in 2024, then plummeted -37bps in 2025.
  • A 4-year view of Return on Equity shows it stood at 2.37% in 2022, then soared by 32bps to 1.62% in 2023, then skyrocketed by 70bps to 0.48% in 2024, then dropped by -10bps to 0.53% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.53% in Q4 2025, 0.78% in Q3 2025, and 0.64% in Q2 2025.